MSF frequently publishes updates, press releases, and other forms of communication about its work in roughly 70 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

June 19, 2015

Doctors Without Borders/Médecins Sans Frontières (MSF) has learned that the Chinese patent office has just denied Gilead Science’s request for a key patent on the hepatitis C drug sofosbuvir. This drug, together with other antivirals, is the backbone of several newer, more effective curative treatments for hepatitis C, yet is exorbitantly priced in many countries, restricting access for people who need it. Hepatitis C is a global public health crisis, with at least 150 million people living with the disease, and 350,000-500,000 people die each year from complications of it.

June 12, 2015

New Delhi/GenevaThe international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today launched a global campaign urging Indian Prime Minister Narendra Modi to stand strong in the face of intensifying multinational pressure to change India’s laws and policies that would severely restrict production of affordable medicines, upon which millions of people around the world depend.

June 12, 2015

Damaging Health Provisions Must be Removed Immediately

June 11, 2015

Judit Rius Sanjuan explains how the Trans-Pacific Partnership could drive up the price of lifesaving drugs in the developing world. View external media.

June 03, 2015

Berlin, June 3, 2015—The global health system remains unprepared for mass disease epidemics, warned the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today, ahead of the G7 summit in Elmau, Germany.

May 28, 2015

In November 2014, Doctors Without Borders/Médecins Sans Frontières (MSF) launched a pediatric project in the region of Bafatá in central Guinea-Bissau. With an infant mortality rate of 116 per 1,000 children, Guinea-Bissau is among the 10 countries with the worst maternal and child health indicators in the world. Here, Isabel Grovas, the MSF medical coordinator in charge of opening the project, discusses the situation.

May 26, 2015

GENEVA—Governments meeting in Geneva for the annual World Health Assembly raised the alarm today on the exorbitant rise in the price to vaccinate a child, and took a decisive step towards addressing the problem by passing a resolution that called for more affordable vaccines and greater transparency of vaccine prices.

January 14, 2015

The Indian Patent Controller today rejected one of Gilead’s key patent applications, which covered the drug sofosbuvir, used to treat hepatitis C (HCV). The oral drug, which first received regulatory approval in the US in November 2013, and has been priced by Gilead at US$84,000 for a treatment course, or $1,000 per pill in the US, has caused a worldwide debate on the pricing of patented medicines. A study from Liverpool University showed that sofosbuvir could be produced for as little as $101 for a three-month treatment course.

August 15, 2014

Statement by MSF International President

 

 

In a briefing organized today by the journalist association “Association des Correspondents Auprès des Nations Unies” (ACUNU) in Geneva, Dr. Joanne Liu, international president of Doctors Without Borders/Médecins Sans Frontières (MSF), gave an account of her recent visit to Guinea, Sierra Leone, and Liberia, sharing what MSF teams are seeing and what more needs to be done to bring the outbreak under control.

April 25, 2014

 

by Estrella Lasry, tropical medicine advisor for MSF

This article originally appeared on the Community Blog of the British Medical Journal.

Pages